Robert A. Berman - 16 Dec 2025 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role
Chief Executive Officer, Director
Signature
/s/ Robert A. Berman
Issuer symbol
NVNO
Transactions as of
16 Dec 2025
Net transactions value
$0
Form type
4
Filing time
18 Dec 2025, 18:24:02 UTC
Previous filing
19 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BERMAN ROBERT ANDREW Chief Executive Officer, Director C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE /s/ Robert A. Berman 18 Dec 2025 0001258360

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVNO Common Stock 22,236 16 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVNO Restricted Stock Units Other $0 -200,000 -100% $0.000000 0 16 Dec 2025 Common Stock 200,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units.